Cancer Genomics Consortium
- Assets
- $580.1k
- Revenue
- $441.0k
- Investments
- $0.0
- Employees
- 0
- Location
- Rochester, MN
- Founding
- 03/2014
- Data as of
- 12/2023
- EIN
- 27-3232063
Organization Overview
Cancer Genomics Consortium is located in Rochester, MN. The organization was established in 2014. According to its NTEE Classification (H12) the organization is classified as: Fund Raising & Fund Distribution, under the broad grouping of Medical Research and related organizations. This organization is an independent organization and not affiliated with a larger national or regional group of organizations. Cancer Genomics Consortium is a 501(c)(3) and as such, is described as a "Charitable or Religous organization or a private foundation" by the IRS.
For the year ending 12/2023, Cancer Genomics Consortium generated $441.0k in total revenue. This organization has experienced exceptional growth, as over the past 8 years, it has increased revenue by an average of 14.7% each year . All expenses for the organization totaled $446.5k during the year ending 12/2023. While expenses have increased by 14.2% per year over the past 8 years. They've been increasing with an increasing level of total revenue. You can explore the organizations financials more deeply in the financial statements section below.
Form
990
Mission & Program ActivityExcerpts From the 990 Filing
TAX YEAR
2023
Describe the Organization's Mission:
Part 3 - Line 1
THE CANCER GENOMICS CONSORTIUM (CGC) IS COMMITTED TO PROVIDING HIGH QUALITY EDUCATION AND PROMOTING BEST LABORATORY PRACTICES IN CLINICAL CANCER GENOMICS.
Describe the Organization's Program Activity:
Part 3 - Line 4a
ANNUAL MEETING - A UNIQUE GATHERING AIMED AT BRINGING THE GLOBAL CLINICAL GENOMIC COMMUNITY TOGETHER TO CREATE AN INCLUSIVE ENVIRONMENT OF COLLABORATION, EDUCATION, NETWORKING AND MENTORSHIP. WITH THE CONTINUING INTER-DISPLINARY PARTNERSHIPS BETWEEN CLINICAL GENOMICISTS (CYTOGENETIC & MOLECULAR), BIOINFORMATICIANS, GENOMIC VARIANT SCIENTISTS, LABORATORY DIRECTORS, RESEARCH SCIENTISTS, PATHOLOGISTS AND ONCOLOGISTS. CGC IS COMMITTED TO PLAYING AN ESSENTIAL ROLE IN TRANSLATING SCIENTIFIC DISCOVERIES INTO THE CLINICAL DIAGONOSTICS SETTING FOR PATIENT CARE AND GUIDING THE BEST PRACTICE TO ENABLE PRECISION MEDICINE AT THE HIGHEST LEVEL. THE MEETING WILL INCLUDE INVITED SCIENTIFIC PRESENTATIONS FROM LEADING SCIENTISTS AND PROFESSIONALS, SELECTED PLATFORM AND POSTER PRESENTATIONS, ROUND TABLE DISCUSSIONS ON TOPICS, EDUCATIONAL WORKSHOPS AS WELL AS AMPLE OPPORTUNITIES TO NETWORK WITH THE INDUSTRY PARTNERS.
OTHER PROGRAMS - THE CGC EARLY CAREER INITIATIVE COMMITTEE ORGANIZES AND PROMOTES INITIATIVES WITHIN CGC TO DEVELOP A COMMUNITY, FACILITATE NETWORKING, AND PROMOTE THE ENGAGEMENT OF EARLY CAREER MEMBERS. THE GOALS OF THE CGC EARLY CAREER COMMITTEE IS TO DEVELOP A COMMUNITY AMONG EARLY CAREER MEMBERS OF THE CGC AND PROVIDE RESOURCES INCLUDING NETWORKING OPPORTUNITIES, MENTORSHIP, BOARD EXAM PREPARATION, JOB SEARCH ADVICE, AND SOCIAL EVENTS. THE EARLY CAREER INITIATIVE COMMITTEE LIAISES WITH OTHER CGC COMMITTEES, INCLUDING THE EDUCATION, MEMBERSHIP, PROGRAM, AND COMMUNICATIONS, IN ORDER TO FURTHER THE INTERESTS OF EARLY CAREER MEMBERS. IN ADDITION, CGC HAS WEBINARS SERIES THAT FOCUSES ON TOPICS OF HIGH INTEREST FOR CGC MEMBERS AND ATTENDEES OF THE CGC ANNUAL MEETING, INCLUDING IMPLEMENTATION OF NEW TECHNOLOGIESIN CLINICAL GENOMIC TESTING, STANDARDS AND RESOURCES FOR INTERPRETATION OF SEQUENCE AND COPY NUMBER VARIANTS, GREMLINE PREDISPOSTIONS TO CANCER, AND NOVEL APPROACHES FOR DETECTION OF STRUCTURAL VARIANTS IN CONSTITUTIONAL AND CANCER SAMPLES.
COMPENDIUM OF CANCER GENOME ABERRATIONS - CCGA IS A COLLABORATIVE PROJECT TO DOCUMENT GENOMIC ABERRATIONS IN CANCER BASED ON THE WHO CLASSIFICATION STRUCTURE AS AN EDUCATIONAL RESOURCE FOR DAY-TO-DAY USE IN CLINICAL CASE INTERPRETATION. HOSTED ON A WIKI PLATFORM, THE CCGA IS DESIGNED TO PROVIDE UP-TO-DATE AND INTEGRATIVE CONTENT, HIGHLIGHTING ACTIONABLE AND DIAGNOSTICALLY-IMPORTANT FEATURES.
Get More from Intellispect for FreeCreate a free account to get more data, nonprofit salaries, advanced search and more.
Board, Officers & Key Employees
| Name (title) | Role | Hours | Compensation |
|---|---|---|---|
Name Not Listed Board Member | Trustee | 0.5 | $0 |
Name Not Listed Junior Board | Trustee | 0.5 | $0 |
Name Not Listed Junior Board | Trustee | 0.5 | $0 |
Name Not Listed Board Member | Trustee | 0.5 | $0 |
Name Not Listed Board Member | Trustee | 0.5 | $0 |
Name Not Listed Secretary | OfficerTrustee | 1 | $0 |
Financial Statements
| Statement of Revenue | |
|---|---|
| Federated campaigns | $0 |
| Membership dues | $0 |
| Fundraising events | $0 |
| Related organizations | $0 |
| Government grants | $0 |
| All other contributions, gifts, grants, and similar amounts not included above | $6,434 |
| Noncash contributions included in lines 1a–1f | $0 |
| Total Revenue from Contributions, Gifts, Grants & Similar | $6,434 |
| Total Program Service Revenue | $410,722 |
| Investment income | $23,884 |
| Tax Exempt Bond Proceeds | $0 |
| Royalties | $0 |
| Net Rental Income | $0 |
| Net Gain/Loss on Asset Sales | $0 |
| Net Income from Fundraising Events | $0 |
| Net Income from Gaming Activities | $0 |
| Net Income from Sales of Inventory | $0 |
| Miscellaneous Revenue | $0 |
| Total Revenue | $441,040 |
| Statement of Expenses | |
|---|---|
| Grants and other assistance to domestic organizations and domestic governments. | $0 |
| Grants and other assistance to domestic individuals. | $0 |
| Grants and other assistance to Foreign Orgs/Individuals | $0 |
| Benefits paid to or for members | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation of current officers, directors, key employees. | $0 |
| Compensation to disqualified persons | $0 |
| Other salaries and wages | $0 |
| Pension plan accruals and contributions | $0 |
| Other employee benefits | $0 |
| Payroll taxes | $0 |
| Fees for services: Management | $142,388 |
| Fees for services: Legal | $9,950 |
| Fees for services: Accounting | $1,200 |
| Fees for services: Lobbying | $0 |
| Fees for services: Fundraising | $0 |
| Fees for services: Investment Management | $0 |
| Fees for services: Other | $0 |
| Advertising and promotion | $0 |
| Office expenses | $0 |
| Information technology | $87,380 |
| Royalties | $0 |
| Occupancy | $0 |
| Travel | $0 |
| Payments of travel or entertainment expenses for any federal, state, or local public officials | $0 |
| Conferences, conventions, and meetings | $0 |
| Interest | $0 |
| Payments to affiliates | $0 |
| Depreciation, depletion, and amortization | $0 |
| Insurance | $1,169 |
| All other expenses | $158 |
| Total functional expenses | $446,547 |
| Balance Sheet | |
|---|---|
| Cash—non-interest-bearing | $50,904 |
| Savings and temporary cash investments | $475,197 |
| Pledges and grants receivable | $0 |
| Accounts receivable, net | $32,592 |
| Loans from Officers, Directors, or Controlling Persons | $0 |
| Loans from Disqualified Persons | $0 |
| Notes and loans receivable | $0 |
| Inventories for sale or use | $0 |
| Prepaid expenses and deferred charges | $21,427 |
| Net Land, buildings, and equipment | $0 |
| Investments—publicly traded securities | $0 |
| Investments—other securities | $0 |
| Investments—program-related | $0 |
| Intangible assets | $0 |
| Other assets | $0 |
| Total assets | $580,120 |
| Accounts payable and accrued expenses | $15,904 |
| Grants payable | $0 |
| Deferred revenue | $57,680 |
| Tax-exempt bond liabilities | $0 |
| Escrow or custodial account liability | $0 |
| Loans and other payables to any current Officer, Director, or Controlling Person | $0 |
| Secured mortgages and notes payable | $0 |
| Unsecured mortgages and notes payable | $0 |
| Other liabilities | $0 |
| Total liabilities | $73,584 |
| Net assets without donor restrictions | $506,536 |
| Net assets with donor restrictions | $0 |
| Capital stock or trust principal, or current funds | $0 |
| Paid-in or capital surplus, or land, building, or equipment fund | $0 |
| Retained earnings, endowment, accumulated income, or other funds | $0 |
| Total liabilities and net assets/fund balances | $580,120 |